Movement Disorders Program Director Fernando Pagan co-led the successful GUMC clinical trial for a drug to reverse symptoms of Parkinson’s disease. Two Georgetown University Medical Center researchers ...
A defect in the blood-brain barrier may play a role in Parkinson’s disease, according to groundbreaking research discovery. Researchers at Georgetown University Medical Center say their finding, ...
Patients with moderately severe Parkinson’s Disease harbor significant defects in blood vessels that act as a gatekeeper between the body’s general circulation and the brain, scientists at Georgetown ...
WASHINGTON – In an unexpected discovery, Georgetown University Medical Center researchers have identified what appears to be a significant vascular defect in patients with moderately severe ...
Charbel Moussa, MBBS, PhD, the senior author of the study, director of the GUMC Translational Neurotherapeutics Program, Georgetown Neurology Associate Professor This work is a continuation of ...
This is Charbel Moussa, MD, PhD Georgetown University Medical Center. Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing ...